Search Results for
S2007Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
Continue Reading »NRG-BR007
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Continue Reading »EA1181
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Continue Reading »A011801
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Continue Reading »S1706
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Continue Reading »A191901
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
Continue Reading »EAZ171
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
Continue Reading »URCC 18007
Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors
Continue Reading »MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)
Continue Reading »NRG-BR004
Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast Cancer
Continue Reading »
